HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Infectious Disease
Cohort
Clinical-immuno-inflammatory signature for Aspergillus–Mucorales co-infection in ICU patients
ICU patients with co-infection show higher but not significant mortality
This single-center observational cohort study of 93 critically ill ICU patients found that a clinical-immuno-inflammatory signature for earl…
Critically ill patients with both Aspergillus and Mucorales infections had higher ICU mortality, but the difference was not statistically si…
Frontiers
Apr 23, 2026
Ophthalmology
Prospective observational study on antifungal resistance in fungal keratitis in South India.
</think>
This primary research article is a prospective observational study of 153 patients with fungal keratitis in South India. It found high rates…
Resistance to common eye drops is rising, making infections harder to cure.
medRxiv
Apr 23, 2026
Infectious Disease
Cohort
Sterile-site yeast isolates linked to fungemia, sepsis, and mortality in a retrospective cohort study.
Blood Infections From Yeast Are Changing—Here’s What Patients Need to Know
This retrospective cohort study analyzed 231 consecutive sterile-site yeast isolates from Nanjing Drum Tower Hospital between 2019 and 2023.…
This study shows that not all yeast infections are the same, and your specific risk factors—like kidney injury or recent surgery—can dramati…
Frontiers
Apr 22, 2026
Drug Pipeline
Sys. Review
Narrative review on essential oils versus traditional antifungal drugs for fungal infections
Nature's Shield: Essential Oils Fight Fungal Resistance
This narrative review synthesizes evidence on essential oils (EOs) and their compounds compared to traditional antifungal drugs for fungal i…
Essential oils from common plants can stop fungal infections more effectively and safely than many traditional medicines.
Frontiers
Apr 19, 2026